Powering ALS Network’s First AI-Based Clinical Trial Finder, DPharm 2025, Our Space Health Data Platform and more…
🏈 Kicking Off Progress in ALS Research – We’re honored to share that TrialX’s global clinical trial finder now powers the ALS Network’s Trial Finder—an AI-driven platform designed to help individuals easily discover clinical trials focused on amyotrophic lateral sclerosis (ALS) and related motor neuron diseases. The new tool offers a personalized, user-friendly search experience—guiding users through tailored questions, smart filters, and clear trial summaries to help them connect with relevant studies and stay informed through a volunteer registry. ALS is a progressive and fatal neuromuscular condition with no known cure, making access to research opportunities all the more vital. Read more.
What’s New at TrialX! 🚀
🚀 With AI dominating the headlines, we’re taking the conversation to where it matters most—DPharm 2025. As an exhibiting sponsor, we invite you to connect with our Co-founder & CEO to explore how we are leveraging AI to advance patient engagement, patient recruitment, and remote data collection and discuss how we can drive innovation together. 👉 Schedule a meet here.
📢 PRODUCT UPDATES
☀️ A Summer of Progress in Celiac Research – Celiac disease affects about 1 in 100 people worldwide, yet many remain undiagnosed. TrialX’s global clinical trial finder now powers a dedicated tool for Beyond Celiac—a nonprofit committed to raising awareness and accelerating research for management of celiac disease and other gluten-related disorders. The tool makes it easier for celiac disease patients and caregivers to find and access clinical trials, with intuitive filters, clear trial summaries, and the option to join a volunteer registry—streamlining the process of matching with studies and staying informed about new research opportunities. 👉 Learn more and explore the Clinical Trial Finder here.
🌌 Expanding Horizons – Space missions demand health monitoring in environments with limited connectivity and extreme conditions—where traditional tools often fall short. TrialX Space Health Systems is an offline-capable, AI-powered platform that collects and analyzes diverse datasets, from wearables to genomics, even beyond Earth’s grid. Remote health research is possible, wherever the mission goes. 👉 Learn More.
Listen to our Executive Chairman, Eric Sandor, share insights on leveraging AI to enhance patient recruitment and engagement. In this Q&A with Andrew Garvey of GSK, he shares our upcoming innovations in AI-powered recruitment solutions, reaffirming our commitment to advancing patient-centric clinical trials and ensuring efficiency, accuracy and inclusivity in AI-driven recruitment. Watch the full panel discussion to learn more.
🎤️ UNSUNG BUT IMPACTFUL VOICES OF CLINICAL RESEARCH HEROES
For some, clinical research is a calling— rooted in compassion, curiosity, and a deep desire to help others make informed decisions about their health. In our latest feature from the – Unsung But Impactful Voices of Clinical Research Heroes series – we’re proud to spotlight Krista Goedel, Digital Content Creator at SanofiStudies.com. With over 20 years of experience in clinical research—Krista now focuses on making clinical research more understandable and approachable for patients. Through her work, she helps bridge the gap between science and the people it’s meant to serve. Her journey reminds us that meaningful engagement begins with empathy, clarity, and trust.👉 Read her full interview here.
RECENT CURETALKS 
🧬 FEATURED CLINICAL STUDIES
Powered by TrialX
Better Sleep, Brighter Minds: Indiana University researchers are studying whether an online relaxation and sleep program can improve well-being in youth ages 11–13 with mild stress. Parents and children will attend 8 weekly virtual sessions, practice relaxation and sleep skills together, and complete surveys over 4 months.
Flicker Photophobia Study: Researchers from Penn Medicine are exploring how flickering light affects people with and without migraine with visual aura. Participants ages 18–40 will wear a light-logging device, complete vision perception tests, and undergo fMRI scans to better understand how the brain responds to flicker.
Acne Vaccine Study: Sanofi researchers are testing an experimental vaccine designed to train the immune system to fight the bacteria that causes acne. About 260 adults ages 18–45 will take part at ~100 study sites. Over about 8 months, they will attend up to 14 clinic visits where researchers will monitor skin health and overall safety.
SunRISe-5: Building on the encouraging findings from the SunRISe-1 trial where 82% of patients were cured of bladder cancer, Janssen Research & Development, LLC is now recruiting patients with high-risk non–muscle invasive bladder cancer who relapsed after BCG treatment, for the Phase 3 study – SunRISe-5. This pivotal trial will assess J&J’s TAR-200 – a pretzel shaped drug delivery device – in a larger population, directly comparing it with intravesical chemotherapy. Results will determine whether TAR-200 can become a new treatment option for bladder cancer.
🌎 AROUND THE WEB
🌟 Cancer breakthrough: A pretzel-shaped device cured 82% of bladder cancer patients in early trials.
🧑🚀 Space health quirk: Astronauts develop stuffy noses in microgravity, and scientists finally know why.
🧠 Brain-to-speech leap: Implant turns thoughts into words with 74% accuracy.
🤖 AI-designed trial: A Parkinson’s therapy created by AI is heading to clinical testing.
‼️ NOTEWORTHY
At TrialX, we strive to revolutionize the way clinical trials are conducted on earth and in space, by focusing on innovative solutions to streamline patient recruitment and remote data collection. Stay tuned for more updates as we continue to look up to the Moon & Mars!
